Skip to main navigation Skip to search Skip to main content

Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study

  • Anho Liem
  • , Anton P. van de Woestijne
  • , Erik Bruijns
  • , Henk W. O. Roeters van Lennep
  • , Job A. J. de Boo
  • , Henk K. van Halteren
  • , Teun P. van Es
  • , J. Wouter Jukema
  • , Arnoud van der Laarse
  • , Aeilko H. Zwinderman
  • , Dirk J. van Veldhuisen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A pilot study was performed to determine the effect of 40,000 IU Epo on myocardial damage in 51 patients with non-ST segment elevation acute coronary syndrome (non-STE ACS). No significant difference in myocardial damage was found, but an increased systolic blood pressure was noticed
Original languageEnglish
Pages (from-to)285-287
JournalInternational journal of cardiology
Volume131
Issue number2
DOIs
Publication statusPublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study'. Together they form a unique fingerprint.

Cite this